The adjuvant therapy has demonstrated varied efficacy for patients.
Sukeina Nasser, PharmD, CPh, PACS
Advertisement
Articles by Sukeina Nasser, PharmD, CPh, PACS
Data shed light on brentuximab vedotin plus nivolumab, bendamustine, or gemcitabine.
Pharmacists can empower their community with essential knowledge for summer skin protection to protect against skin cancer.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Tavapadon, First D1/D5 Agonist for Parkinson Disease
2
Pharmacists Can Close CKD Medication Adherence Gaps, PHTI Says
3
FDA Approves Tiratricol, First Treatment for MCT8 Deficiency
4
Expert Q&A: Researcher Urges Autonomic Assessment for Patients With Long COVID
5